Sent to BBCI probably screwed it up, but this is what I sent to the BBC
Dear sir/Madam, I would like to bring to your attention a small Canadian clinical stage pharmaceutical company which may be worthy of further research by the BBC. Although currently under the radar their research and development of light activated compounds, (PDC’s) is nothing short of phenomenal. Their phase 1b trial for non muscle invasive bladder cancer (NMIBC) has met with a 100% success rate
and they are currently preparing for phase 2 trials.
Their patent protected TLD-1433 light activated drug combined with transferrin to form Rutherrin has also proven successful on Glioblastoma brain cancer (GBM) and lung cancer in Vitro and in mice. The companies name is Theralase Technologies and their press releases can be viewed at theralase.com/press-releases/. As is most often the case small companies remain invisible until that magic eureka moment. I feel that moment is fast approaching for Theralase and may be worthy of an some attention by the BBC.
As an added incentive I would like to point out that Canada is well noted for some stunning world changing medical breakthroughs during the last century. A few to mention are: 1920, Sir Frederick Banting, (Insulin). 1950, Dr. Wilfrid Bigelow (How to lower body core temperature, making heart surgery safe). 1961, Drs. James Till and Ernest McCulloch (Their techniques applied to stem cell research & discovering transplantable stem cells). 1984, Dr. Tak Wah Mak, (His discovery of T-cell receptors, a major step in cancer immunology).
1996, Dr. Julio Montaner, (His success in turning Hiv/Aids from a death sentence to a chronic disease). Again, in closing I am hoping that Theralase will get some well deserved attention. Respectfully,